Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-26

Clinical Trial Update: Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety and efficacy trial evaluating ursodeoxycholic acid in pediatric primary sclerosing cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: University of Tennessee | Conditions: Primary Sclerosing Cholangitis | Phase 1 | Status: COMPLETED